Related Experiment Videos
Apolipoprotein E genotype in elderly nondemented subjects without senile changes in the brain
1Department of Neurology, Tokyo Medical and Dental University, Japan.
Annals of Neurology
|August 1, 1996
Summary
A small number of elderly individuals age without brain changes like plaques. The study found that specific forms of the apolipoprotein E gene are linked to this healthy brain aging process.
Area of Science:
- Neuroscience
- Genetics
- Gerontology
Background:
- Brain aging is often characterized by senile plaques, neurofibrillary tangles, and amyloid angiopathy.
- A minority of elderly individuals exhibit brains free from these age-related pathological changes.
- Understanding the factors contributing to healthy brain aging is crucial for public health.
Purpose of the Study:
- To investigate the association between apolipoprotein E (APOE) gene alleles and brain aging without senile changes in the elderly.
- To identify genetic markers that may protect against age-related neuropathology.
Main Methods:
- Analysis of apolipoprotein E (APOE) gene allele frequencies in elderly subjects.
- Correlation of APOE genotype with the presence or absence of senile plaques, neurofibrillary tangles, and amyloid angiopathy in brain tissue.
- Statistical evaluation of allele frequency differences between groups.
Main Results:
- An increased frequency of the APOE epsilon 2 allele was observed in elderly individuals with brains free of senile changes.
- A decreased frequency of the APOE epsilon 4 allele was associated with healthy brain aging without neuropathology.
- These findings suggest a protective role for APOE epsilon 2 and a risk-associated role for APOE epsilon 4 in brain aging.
Conclusions:
- The APOE epsilon 2 allele may confer protection against the development of senile plaques, neurofibrillary tangles, and amyloid angiopathy.
- The APOE epsilon 4 allele appears to be a risk factor for age-related neuropathology in the brain.
- Genetic variations in the APOE gene play a significant role in determining the trajectory of brain aging.